Abstract
The application of quality control and assurance procedures to the components of animal cell cultures has transformed what was an art to a viable industrial technology. This results in the successful large scale operation of such cultures. However it is clear that the cost of obtaining a license to produce materials from animal cells in culture severely impedes the movement of products into the market place. It is therefore necessary to examine in more detail the reasons for the reluctance of the regulatory authorities to issue product licences and in particular to appreciate the way ethical issues influence this process. This paper reviews these issues and indicates a way ahead.
Keywords: animal cells, commercial exploitation, ethics, value, oxygen
Full Text
The Full Text of this article is available as a PDF (29.1 KB).
References
- Birch JR, Bonnerjea J, Flatman S, Vranch S. The Production of Monoclonal Antibodies. In: Birch JR, Lennox ES, editors. Monoclonal Antibodies, Principles and Applications. New York: Pub Wiley-Liss; 1996. p. 232. [Google Scholar]
- Birch JR, Bonnerjea J, Flatman S, Vranch S. The Production of Monoclonal Antibodies. In: Birch JR, Lennox ES, editors. Monoclonal Antibodies, Pinciples and Applications. New York: Pub Wiley-Liss; 1996. pp. 235–236. [Google Scholar]
- Cherry RS, Papoutsakis E. Understanding and controlling fluid-mechanical injury of animal cells in bioreactors. In: Spier RE, Griffiths JB, editors. Animal Cell Biotechnology. London: Academic Press; 1990. pp. 72–122. [Google Scholar]
- Guderman F, Lutkemeyer D, Lehmann J. Design of a bubble-swarm bioreactor for animal cell culture. Cytotechnology. 1994;15:301–309. doi: 10.1007/BF00762405. [DOI] [PubMed] [Google Scholar]
- Handa-Corrigan A. Oxygenating animal cell cultures: the remaining problems. In: Spier RE, Griffiths JB, editors. Animal Cell Biotechnology. London: Academic Press; 1990. pp. 123–132. [Google Scholar]
- Kessler DA, Feiden KL. Faster Evaluation of Vital Drugs. Scientific American. 1995;272:26–32. doi: 10.1038/scientificamerican0395-48. [DOI] [PubMed] [Google Scholar]
- McCullough K, Spier RE. Monoclonal Antibodies in biotechnology: theoretical and practical aspects. Cambridge: Cambridge University Press; 1990. pp. 282–284. [Google Scholar]
- Spier RE, Whiteside JP. The description of a device which facilitates the oxygenation of microcarrier cultures. Dev. Biol. Standard. 1983;55:151–152. [PubMed] [Google Scholar]
- Spier RE, Whiteside JPW. The oxygenation of animal cell cultures by bubbles. In: Spier RE, Griffiths JB, editors. Animal Cell Biotechnology. London: Academic Press; 1990. pp. 133–148. [Google Scholar]
- Spier RE. Bioreactor Design for Animal Cell Cultures: With Special Reference to Mass Transfer. In: Moreita AR, Wallace KK, editors. Computer and Information Science Applications in Bioprocess Engineering. the Netherlands: Pub Kluwer Acad.; 1996. pp. 325–347. [Google Scholar]
- Spier RE. Science and Engineering Ethics on the Acceptability of Biopharmaceuticals. 1996;2:291–306. doi: 10.1007/BF02583915. [DOI] [PubMed] [Google Scholar]
- Thomas CR, Al-Rubei M, Zhang Z. Prediction of mechanical damage to animal cells in turbulence. Cytotechnology. 1994;15:29–335. doi: 10.1007/BF00762408. [DOI] [PubMed] [Google Scholar]
- Vagelos PR. Are prescription drug proces too high. Science. 1991;252:1080–1084. doi: 10.1126/science.252.5009.1080. [DOI] [PubMed] [Google Scholar]
- Wolfe T. The righ stuff. London: Black Swan Books; 1979. [Google Scholar]
- Zhang S, Handa-Corrigan A, Soier RE. Oxygen transfer propeties of bubbles in animal cell culture media. Biotech Bioeng. 1992;40:252–259. doi: 10.1002/bit.260400209. [DOI] [PubMed] [Google Scholar]